SG6784G - Antihypercholesteraemic agent,monacolin k,and its preparation - Google Patents

Antihypercholesteraemic agent,monacolin k,and its preparation

Info

Publication number
SG6784G
SG6784G SG67/84A SG6784A SG6784G SG 6784 G SG6784 G SG 6784G SG 67/84 A SG67/84 A SG 67/84A SG 6784 A SG6784 A SG 6784A SG 6784 G SG6784 G SG 6784G
Authority
SG
Singapore
Prior art keywords
antihypercholesteraemic
monacolin
agent
preparation
antihypercholesteraemic agent
Prior art date
Application number
SG67/84A
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SG6784G publication Critical patent/SG6784G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
SG67/84A 1979-02-20 1984-01-24 Antihypercholesteraemic agent,monacolin k,and its preparation SG6784G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (en) 1979-02-20 1979-02-20 New physiologically active substance monacolin K and its production method

Publications (1)

Publication Number Publication Date
SG6784G true SG6784G (en) 1985-02-08

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
SG67/84A SG6784G (en) 1979-02-20 1984-01-24 Antihypercholesteraemic agent,monacolin k,and its preparation

Country Status (27)

Country Link
JP (1) JPS5925599B2 (en)
KR (1) KR830002801B1 (en)
AT (1) AT373915B (en)
AU (1) AU532626B2 (en)
BE (1) BE881825A (en)
CA (1) CA1129794A (en)
CH (1) CH645890A5 (en)
DD (1) DD154494A5 (en)
DE (2) DE3051175C2 (en)
DK (2) DK149095C (en)
ES (1) ES8103171A1 (en)
FI (1) FI66427C (en)
FR (1) FR2449685B1 (en)
GB (1) GB2046737B (en)
HU (1) HU182069B (en)
IE (1) IE49743B1 (en)
IT (1) IT1175260B (en)
MX (1) MX6314E (en)
NL (1) NL191540C (en)
NO (1) NO153974C (en)
NZ (1) NZ192919A (en)
PH (1) PH15145A (en)
PL (1) PL124304B1 (en)
SE (1) SE453301B (en)
SG (1) SG6784G (en)
SU (2) SU1158048A3 (en)
ZA (1) ZA80962B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (en) * 1980-03-31 1994-11-16 三共株式会社 MB-530A derivative
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5835144A (en) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb-530b derivative and its preparation
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (en) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 Tetralin derivatives as HMG-CoA reductase inhibitors
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US6500651B1 (en) 1998-03-20 2002-12-31 Biogal Gyogyszergyar Rt. Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
US6387258B1 (en) 2000-02-24 2002-05-14 Biogal Gyogyszergyar Rt. Method of purifying statins from a fermentation broth
TR200403001T3 (en) 2000-03-03 2005-02-21 Plus Chemical, S.A. A process for the treatment of lovastatin and simvastatin with reduced dimeric impurity levels
KR20010095780A (en) * 2000-04-12 2001-11-07 나가오카 마사시 Embryo monascus
IN192861B (en) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
CN1273608C (en) * 2001-02-09 2006-09-06 荷兰联合利华有限公司 Process for preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (en) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 Preventive and Dietary Supplement for adult chronic disease
KR100710500B1 (en) 2005-05-18 2007-04-24 고려대학교 산학협력단 Method for producing Monacolin K using Monascus sp
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (en) 2012-10-12 2013-09-30 Ion Gigel Fulga Composition for the treatment or prevention of dyslipidemias
CN110331151A (en) * 2019-04-11 2019-10-15 北京工商大学 The construction method of purple Monascus mokH gene overexpression bacterial strain
CN111297938A (en) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 Method for detecting lovastatin in composition for assisting in reducing blood fat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
GR69216B (en) * 1979-06-15 1982-05-07 Merck & Co Inc

Also Published As

Publication number Publication date
NO800451L (en) 1980-08-21
DK21889D0 (en) 1989-01-18
ZA80962B (en) 1981-03-25
SU969702A1 (en) 1982-10-30
NO153974C (en) 1986-06-25
CA1129794A (en) 1982-08-17
KR830002801B1 (en) 1983-12-16
FR2449685B1 (en) 1985-06-28
NL191540C (en) 1995-09-04
NZ192919A (en) 1984-07-06
SE8001339L (en) 1980-08-21
CH645890A5 (en) 1984-10-31
DE3006216A1 (en) 1980-09-04
DK149095B (en) 1986-01-20
PH15145A (en) 1982-08-24
NL8001041A (en) 1980-08-22
ES488796A0 (en) 1981-02-16
FI66427C (en) 1984-10-10
FR2449685A1 (en) 1980-09-19
BE881825A (en) 1980-08-20
NO153974B (en) 1986-03-17
SE453301B (en) 1988-01-25
AU532626B2 (en) 1983-10-06
FI800506A (en) 1980-08-21
IT1175260B (en) 1987-07-01
DE3006216C2 (en) 1985-10-31
SU1158048A3 (en) 1985-05-23
DD154494A5 (en) 1982-03-24
DK73080A (en) 1980-08-21
ATA92980A (en) 1983-07-15
JPS55111790A (en) 1980-08-28
IE800321L (en) 1980-08-20
AT373915B (en) 1984-03-12
GB2046737A (en) 1980-11-19
DK21889A (en) 1989-01-18
PL222120A1 (en) 1980-10-20
NL191540B (en) 1995-05-01
IT8067262A0 (en) 1980-02-20
AU5567380A (en) 1980-08-28
DK149095C (en) 1986-06-16
FI66427B (en) 1984-06-29
KR830002030A (en) 1983-05-21
PL124304B1 (en) 1983-01-31
ES8103171A1 (en) 1981-02-16
HU182069B (en) 1983-12-28
GB2046737B (en) 1983-01-12
MX6314E (en) 1985-04-01
IE49743B1 (en) 1985-12-11
JPS5925599B2 (en) 1984-06-19
DE3051175C2 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
ZA80962B (en) Antihypercholesteraemic agent,monacolin k,and its preparation
IL56774A0 (en) Arylsulfamates,their preparation and their use as hermicid
IL60065A0 (en) Dietetic agent and its preparation
ZA806626B (en) Absorbent products,processes and compositions
DE3061392D1 (en) Demolition agent, its preparation and its use
IL60138A (en) 7-(-2-aminothiazolyl-2-methoxy-imino acetamido)-3-thiovinyl-cephalosporins,their preparation and compositions containing them
DE3061010D1 (en) Substituted acetophenones, preparations containing them and processes for their preparation
JPS55133376A (en) 55substituted pyranone compound and its use as medicine
JPS565207A (en) Tireeliner and its preparation
IL56882A0 (en) Acylated1-azolyl-2-hydroxy-butane derivatives,their preparation and their use asfungicides
GB2061306B (en) 1,3-glucanpolyol its preparation and composition comprising it
NZ193324A (en) Preparation of n2-phenyl-2,6-diaminonebularines
IL58525A (en) 24,24-difluoro-25-hydroxychole-calciferol and its preparation
AU528732B2 (en) Preparation of 4-hydroxy-5-alkyl and 2, 5-dialkyl-3-oxo-2h-furans
DE3067996D1 (en) Microbial polysaccharide, its preparation and use
DE2960021D1 (en) Acyloxy-2-butenes, their preparation and their use for the preparation of 4-acetoxytiglinaldehyde
DE2961268D1 (en) Bicyclo-compounds, processes for their preparation and their application
JPS55133375A (en) 66substituted pyranone compound and its use as medicine
IL54275A0 (en) Substituted bis-benzimidazolyl compounds, preparation and use thereof
DE2967095D1 (en) Phenyliminomethyl-3-pyridine derivatives, their preparation and use
DE2966446D1 (en) Beta-lactam compounds, their preparation and use
DE3064789D1 (en) New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
DE3071198D1 (en) Acridinones, their preparation and use; intermediates and their preparation
GB2123421B (en) 2,6,6-trimethyl-cyclohex-3-en-1-one and preparation of b-damascenone therefrom
GB2030977B (en) 2,1-benzisothiazoles and preparation thereof